Skip to main content
Premium Trial:

Request an Annual Quote

ABI Ships First SOLiD Sequencer to Stanford to Kick Off Early-Access Program

NEW YORK (GenomeWeb News) - Applied Biosystems said today it has shipped its SOLiD next-generation sequencing technology to Stanford University  and other research institutions through an early-access program, and is developing new applications for the system through collaborations with other academic institutions.
The company did not say which other institutions have plans to buy the system, which uses oligonucleotide ligation and detection for high-throughput DNA analysis.
The SOLiD system differs from polymerase sequencing approaches in that it uses stepwise ligation, ABI said. The company said the technology has applications in whole-genome sequencing, medical sequencing, genotyping, gene expression, and small RNA discovery. 
ABI acquired the technology for the SOLiD system from Agencourt Personal Genomics last year. Since that time, the company said it has increased sample throughput five-fold, and has increased the base read length 66 percent.
ABI said it is developing new applications for the system through collaborations with Stanford, the Broad Institute, the Wellcome Trust Sanger Institute, Baylor College of Medicine, the Joint Genome Institute, the University of Queensland, and Washington University, "among others.”
The system offers 2-base encoding, which interrogates each base twice in order to reduce sequencing errors, and can generate more than a gigabase of useable data per run, ABI said.
Mark Stevenson, president for ABI’s molecular and cell biology division, said in a statement that the SOLiD system has "the best commercial viability among more than 40 next-generation sequencing technologies we evaluated," and that the company will continue its development collaborations to refine the system and develop new applications.
Arend Sidow, an associate professor at Stanford School of Medicine, has used the system to analyze 282 megabases of aligned sequence data, and used it to help create a high-resolution map of nucleosome positioning in Caenorhabditis elegans.
George Weinstock, a director at the Human Genome Sequencing Center at the Baylor College of Medicine, said in a statement that when he used the ABI system to resequence the genome of a strain of Escherichia coli for validation assembly it identified a large duplication that was missed in earlier Sanger sequencing runs.
Weinstock said the SOLiD system "will enable us to generate highly accurate sequence data for infectious disease pathogens and other microbes."

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.